Here’s what you need to know before investing in Amgen (AMGN)
The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely successful. While different brands of…
28 articles, transcripts, and reports
The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely successful. While different brands of…
Amgen Inc (NASDAQ: AMGN) Q4 2020 earnings call dated Feb. 02, 2021. Corporate Participants: Arvind Sood — Vice President, Investor Relations Robert A. Bradway — Chairman and Chief Executive…
Amgen Inc. (NASDAQ: AMGN) Q3 2020 earnings call dated Oct. 28, 2020 Corporate Participants: Arvind Sood — Vice President of Investor Relations Robert A. Bradway — Chairman and Chief Executive…
Amgen Inc (NASDAQ: AMGN) Q2 2020 earnings call dated July 28, 2020 Corporate Participants: Arvind Sood — Vice President of Investor Relations Robert A. Bradway — Chairman and Chief…
Amgen Inc (AMGN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Arvind Sood — Vice President of Investor Relations Robert A. Bradway — Chairman and Chief Executive…
Amgen’s (NASDAQ: AMGN) top and bottom line in the first quarter of 2020 beat analysts’ estimates. The biotech firm’s adjusted earnings per share surged 17%…
Amgen Inc (NASDAQ: AMGN) Q4 2019 Earnings Conference Call January 30, 2020 Corporate Participants: Arvind Sood — Vice President of Investor Relations Robert A. Bradway — Chairman and Chief Executive…
Amgen Inc. (NASDAQ: AMGN) topped revenue and earnings estimates for the fourth quarter of 2019. However, shares fell 2.7% in aftermarket hours as the outlook…